Brief Article
Copyright ©2012 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Diabetes. Mar 15, 2012; 3(3): 54-59
Published online Mar 15, 2012. doi: 10.4239/wjd.v3.i3.54
ApoE isoforms, treatment of diabetes and the risk of coronary heart disease
Hideki Ehara, Ritsuko Yamamoto-Honda, Hiroji Kitazato, Yoshihiko Takahashi, Shoji Kawazu, Yasuo Akanuma, Mitsuhiko Noda
Hideki Ehara, Hiroji Kitazato, Shoji Kawazu, Yasuo Akanuma, the Institute for Adult Diseases, Asahi Life Foundation, 2-2-6, Nihonbashi-bakurocho, Chuo-ku, Tokyo 103-0002, Japan
Hideki Ehara, Ehara Medical Clinic, 1-10 Shouwa-cho, Tuyama-city, Okayama 708-0886, Japan
Ritsuko Yamamoto-Honda, Yoshihiko Takahashi, Mitsuhiko Noda, Department of Diabetes and Metabolic Medicine and Diabetes Research Center, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku, Tokyo 162-8655, Japan
Hiroji Kitazato, Department of Diabetes and Endocrinology, Oomori Red Cross Hospital 4-30-11 Chuo, Oota-ku, Tokyo 143-8527, Japan
Author contributions: Ehara H, Kitazato H, Akanuma Y and Noda M designed the research; Ehara H, Yamamoto-Honda R, Kitazato H, Kawazu S and Akanuma Y collected the data; Takahashi Y contributed the analytical tools; Yamamoto-Honda R analyzed the data; Yamamoto-Honda R and Noda M wrote the paper.
Correspondence to: Dr. Ritsuko Yamamoto-Honda, Chief, Department of Diabetes and Metabolic Medicine and Diabetes Research Center, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku, Tokyo 162-8655, Japan. rithonda@hosp.ncgm.go.jp
Telephone: +81-3-32027181 Fax: +81-3-52736930
Received: October 10, 2011
Revised: March 2, 2012
Accepted: March 9, 2012
Published online: March 15, 2012
Abstract

AIM: To analyze the risk of coronary heart disease in patients with type 2 diabetes mellitus (T2DM) receiving standard medical treatment.

METHODS: We performed a retrospective chart analysis of 269 middle-aged patients (age 45-64 years, mean age, 53.9 ± 5.5 years) with T2DM and without atherosclerotic cardiovascular events who underwent typing to determine their apolipoprotein E (apoE) isoforms. The apoE isoforms were determined using isoelectric focusing, followed by immunoblotting. We retrospectively evaluated the charts of the 269 patients, recorded between their first visit to the hospital (the study’s start point, between 1987 and 1992) and the occurrence of an atherosclerotic cardiovascular event (the study’s endpoint) or January 2004, whichever came first. The age-adjusted mean values and the prevalences of covariates were calculated to compare the laboratory data among the apoE phenotypes. To investigate the association of risk factors with the incidence of coronary heart disease during the follow-up period, monovariate and multivariate Cox regression models were used.

RESULTS: At enrollment, the mean serum low density lipoprotein (LDL) cholesterol levels were lowest (2.92 ± 0.89 mmol/L) among the subjects with apoE2 (apoE2/2 or apoE2/3) and highest (3.52 ± 0.77 mmol/L) among the subjects with apoE4 (apoE3/4 or apoE4/4). No significant differences in mean age or the percentage of smokers were observed among the three groups. Furthermore, no significant differences were observed in the systolic and diastolic blood pressures, body mass index, HbA1c level or serum triglyceride levels among the three groups. There were 47 cases of coronary heart disease over 3285 person-years of follow-up. An age-adjusted multivariate Cox proportional model identified diabetic retinopathy (hazard ratio, 2.38, 95% CI: 1.28-4.43, P = 0.006), a high systolic blood pressure (hazard ratio, 1.04, 95% CI: 1.02-1.06, P < 0.001) and high HbA1c values (hazard ratio, 1.19, 95% CI: 1.02-1.38, P = 0.0029), but not the LDL cholesterol value at enrollment (hazard ratio, 1.01, 95% CI: 0.97-1.05, P = 0.77) nor the specific apoE isoform, as significant predictors of coronary heart disease.

CONCLUSION: Under standard medical treatment of diabetes, including the control of LDL cholesterol levels, the apoE4 isoform was not associated with coronary heart disease among T2DM patients.

Keywords: Type 2 diabetes, Atherosclerosis, Apolipoprotein E isoform